Filing Details

Accession Number:
0000711377-14-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-28 16:50:37
Reporting Period:
2014-03-26
Filing Date:
2014-03-28
Accepted Time:
2014-03-28 16:50:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188987 A Terri Morrical Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-03-26 13,950 $18.68 56,812 No 4 M Direct
Common Stock Disposition 2014-03-26 13,950 $45.37 42,862 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2014-03-26 13,950 $0.00 13,950 $18.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
94,048 2015-08-24 No 4 M Direct
Footnotes
  1. Options were granted on 8/24/10, have five years lives, and vest equally in annual installments on each anniversary date of the grant. The grants expire on 8/24/2015